SEVBI, a nonprofit organisation, creates an enabling basis for prescription-free and off-label prescription treatment options for patients with neuromuscular and neurological diseases – such as amyotrophic lateral sclerosis (ALS) - based on sound scientific and medical information.
All within the guidelines for off-label prescribing, and in collaboration with patients, patient advocates, physicians, pharmacologists, pharmacists, legal experts and relevant governance boards.